Dr Alberta Hoi - Researcher Profile

We do not have a photograph of this person yet.

Address

Faculty of Medicine, Nursing & Health Sciences
Monash University, Clayton

Biography

Alberta works in the Faculty of Medicine, Nursing & Health Sciences at Monash University as a Research Fellow.

Qualifications

FELLOW OF THE ROYAL AUSTRALASIAN COLLEGE OF PHYSIC
Institution: The Royal Australasian College of Physicians
Year awarded: 2003
BACHELOR OF MEDICINE & BACHELOR OF SURGERY (MBBS)
Institution: The University of Melbourne
Year awarded: 1996

Publications

Journal Articles

Connelly, K., Morand, E.F., Hoi, A., 2012, Asian ethnicity in systemic lupus erythematosus: an Australian perspective, Internal Medicine Journal [P], vol epub, Wiley-Blackwell Publishing Asia, Australia, p. epub.

Cheng, Q., Hoi, A., Hickey, M., Morand, E., 2012, Lymphocytes from systemic lupus erythematosus patients display increased spreading on VCAM-1, an effect associated with active renal involvement, Lupus [P], vol 21, issue 6, Sage Publications Ltd, United Kingdom, pp. 632-641.

Ngian, G., Naidoo, P., Morand, E., Hoi, A., 2011, Smooth muscle myopathy as an underrecognized manifestation of active systemic lupus erythematosus, Internal Medicine Journal [P], vol 41, issue 6, Wiley-Blackwell Publishing Asia, Australia, pp. 495-498.

Summers, S.A., Hoi, A., Steinmetz, O., O'Sullivan, K., Ooi, J., Odobasic, D., Akira, S., Kitching, A.R., Holdsworth, S.R., 2010, TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy, Journal Of Autoimmunity [P], vol 35, issue 4, Academic Press, United Kingdom, pp. 291-298.

Hoi, A., Iskander, M.N., Morand, E.F., 2007, Macrophage migration inhibitory factor: A therapeutic target across inflammatory diseases, Inflammation & Allergy - Drug Targets, vol 6, issue 3, Bentham Science Publishers Ltd, Netherlands, pp. 183-190.

Hoi, A., Hickey, M.J., Hall, P.H., Yamana, J., O'Sullivan, K., Santos, L.L., James, W.G.M., Kitching, A.R., Morand, E.F., 2006, Macrophage migration inhibitory factor deficiency attenuates macrophage recruitment, glomerulonephritis, and lethality in MRL/lpr mice, Journal of Immunology, vol 177, issue 8, American Association of Immunologists, Bethesda USA, pp. 5687-5696.

Hoi, A., Morand, E.F., 2003, Churg-Strauss syndrome? the use of cyclophosphamide in severe complications, Rheumatology, vol 42, Oxford University Press, England, pp. 390-391.

Hoi, A.Y., Morand, E.F., Leech, M.T., 2003, Is macrophage migration inhibitory factor a therapeutic target in systemic lupus erythematosus?, Immunology and Cell Biology, vol 81, issue 5, Blackwell Publishing Asia, Carlton Vic Australia, pp. 367-373.